XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 665,991 $ 657,152
Adjustments to net income:    
Depreciation and amortization 1,788,973 1,419,321
Amortization of share-based compensation 47,671 20,154
Non-cash revenue adjustments (95,324) (51,272)
Amortization of deferred financing costs 17,694 19,498
Foreign currency and unrealized derivative (gain) loss, net (33,582) 10,188
Non-cash interest expense (income) 9,179 (5,390)
Gain on sales of real estate (92,290) (19,675)
Equity in earnings of unconsolidated entities (5,440) (411)
Distributions on common equity from unconsolidated entities 15,608 0
Provisions for impairment 282,867 59,801
Change in assets and liabilities    
Accounts receivable and other assets 40,338 (17,538)
Accounts payable, accrued expenses and other liabilities (36,471) 161,527
Net cash provided by operating activities 2,601,313 2,198,111
CASH FLOWS FROM INVESTING ACTIVITIES    
Investment in real estate (1,611,794) (6,702,140)
Improvements to real estate, including leasing costs (85,204) (47,107)
Investment in unconsolidated entities (57,014) 0
Investment in loans (377,490) 0
Proceeds from sales of real estate 451,365 92,772
Return of investment from unconsolidated entities 0 3,927
Proceeds from note receivable 51,562 0
Insurance proceeds received 2,418 15,177
Non-refundable escrow deposits (38,750) (1,188)
Net cash acquired in merger 93,683 0
Net cash used in investing activities (1,571,224) (6,638,559)
CASH FLOWS FROM FINANCING ACTIVITIES    
Cash distributions to common stockholders (1,999,858) (1,555,679)
Cash distributions to preferred stockholders (7,763) 0
Borrowings on line of credit and commercial paper programs 24,698,502 33,021,401
Payments on line of credit and commercial paper programs (25,079,449) (34,909,165)
Proceeds from term loan 0 1,029,383
Principal payment on term loan (250,000) 0
Proceeds from notes payable issued 2,657,925 3,263,294
Principal payment on notes payable (849,999) 0
Principal payments on mortgages payable (626,321) (20,842)
Proceeds from common stock offerings, net 809,910 3,849,963
Proceeds from dividend reinvestment and stock purchase plan 8,814 8,382
Redemption of preferred stock (172,510) 0
Distributions to noncontrolling interests (7,185) (5,585)
Net receipts on derivative settlements 0 2,191
Debt issuance costs (59,285) (35,014)
Other items, including shares withheld upon vesting (8,591) (6,181)
Net cash (used in) provided by financing activities (885,810) 4,642,148
Effect of exchange rate changes on cash and cash equivalents 11,423 2,083
Net increase in cash, cash equivalents and restricted cash 155,702 203,783
Cash, cash equivalents and restricted cash, beginning of period 292,175 226,881
Cash, cash equivalents and restricted cash, end of period 447,877 430,664
Mortgages    
Adjustments to net income:    
Amortization of net premiums (18) (9,597)
CASH FLOWS FROM FINANCING ACTIVITIES    
Principal payments on mortgages payable (626,300)  
Notes payable    
Adjustments to net income:    
Amortization of net premiums $ (3,883) $ (45,647)